Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
RMD Open|February 5, 2019
Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to considerJulia Unger, Polina Putrik, Frank Buttgereit, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|May 16, 2014
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatologyMaya H Buch, Lucia Silva-Fernandez, Loreto Carmona, et al.
Annals of the Rheumatic Diseases|March 18, 2016
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiativeAthan Baillet, Laure Gossec, Loreto Carmona, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Rheumatology (Oxford, England)|November 30, 2014
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registersLianne Kearsley-Fleet, Jakub Závada, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|October 2, 2020
EULAR definition of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia Mt Roodenrijs, Paco Mj Welsing, et al.
Annals of the Rheumatic Diseases|August 19, 2021
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia M T Roodenrijs, Paco M J Welsing, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
Pageof 11